Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Leukemia

Outcomes of transplantation with partial T-cell depletion of matched or mismatched unrelated or partially matched related donor bone marrow in children and adolescents with leukemias

Bone Marrow Transplantation volume 35, pages 151–158 (2005)Cite this article

Abstract

Summary:

Graft-versus-host disease (GVHD) remains a major barrier to successful hematopoietic stem cell transplant for patients who lack a matched related donor. Partial T-cell depletion (TCD) of the graft may decrease the risk of severe GVHD with unrelated donors (URD) and partially matched related donors (PMRD) while retaining an antileukemic effect. We analyzed our experience using URD and PMRD for pediatric patients with leukemias from 1990 to 2001. A subgroup of ‘matched’ URD donor pairs was retrospectively analyzed for high-resolution class I. Partial TCD was accomplished with monoclonal antibody T10B9 or OKT3 and complement. There were 76 URD (45% matched) and 28 PMRD recipients. Event-free survival (EFS) was 38.3%, and overall survival (OS) 45.1% at 3 years. On multivariate analysis, there was no difference in survival based upon marrow source, but nonrelapse mortality was higher with the use of PMRD. Relapse occurred in 6% of ALL patients, and 22.8% of AML/MDS patients. Grades III–IV GVHD was observed in only 6.7% of patients. Partial TCD allows use of matched or mismatched URD, or PMRD with little mortality from GVHD, durable engraftment, and no increase in relapse risk.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Balduzzi A, Gooley T, Anasetti C et al. Unrelated donor marrow transplantation in children. Blood 1995; 86: 3247–3256.

    CAS  PubMed  Google Scholar 

  2. Davies S, Ramsay N, Haake R et al. Comparison of engraftment in recipients of matched sibling or unrelated donor marrow allografts. Bone Marrow Transplant 1994; 13: 51–57.

    CAS  PubMed  Google Scholar 

  3. Vettenranta K, Saarinen-Pihkala U, Cornish J et al. Pediatric marrow transplantation for acute leukemia using unrelated donors and T-replete or -depleted grafts: a case matched analysis. Bone Marrow Transplant 2000; 25: 395–399.

    Article  CAS  PubMed  Google Scholar 

  4. Green A, Clarke EHL, Hunt L et al. Children with acute lymphoblastic leukemia who received T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome. Blood 1999; 94: 2236–2246.

    CAS  PubMed  Google Scholar 

  5. Kernan N, Bordignon C, Heller G et al. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood 1989; 74: 2227–2236.

    CAS  PubMed  Google Scholar 

  6. Hopkins K . The basic lymphocyte microcytoxicity tests: standard and AHG enhancement. In: Amy K, Geoffrey L, Rosemarie S (eds). ASHI Laboratory Manual, 4th edn. American Society for Histocompatibility and Immunogenetics, 2000, pp 1–7.

    Google Scholar 

  7. Ballas M, Oechsle T, Eiermann C et al. A DRB oligonucleotide typing system defining 50 of 56 DRB alleles. In: Tsuji K, Aizawa M, Sasazuki T (eds). Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford University Press: New York, 1992, p 311.

    Google Scholar 

  8. Hurley C, Maiers M, Ng J et al. Large-scale DNA-based typing of HLA-A and HLA-B at low resolution is highly accurate, specific and reliable. Tissue Antigens 2000; 55: 352–358.

    Article  CAS  PubMed  Google Scholar 

  9. Casper J, Camitta B, Truitt R et al. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 1995; 85: 2354–2364.

    CAS  PubMed  Google Scholar 

  10. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295–304.

    Article  CAS  PubMed  Google Scholar 

  11. Storb R, Prentice R, Sullivan K et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by bone marrow transplantation from HLA-identical siblings. Ann Int Med 1983; 98: 461–466.

    Article  CAS  PubMed  Google Scholar 

  12. Bunin N, Carston M, Wall D et al. Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 2002; 99: 3151–3157.

    Article  CAS  PubMed  Google Scholar 

  13. Godder K, Pati A, Abhyankar S et al. De novo chronic graft-versus-host disease presenting as hemolytic anemia following partially mismatched related donor bone marrow transplant. Bone Marrow Transplant 1997; 19: 813–817.

    Article  CAS  PubMed  Google Scholar 

  14. Davies S, Wagner J, Shu X et al. Unrelated donor bone marrow transplantation for children with acute leukemia. J Clin Oncol 1997; 15: 557–565.

    Article  CAS  PubMed  Google Scholar 

  15. Woolfrey A, Anasetti C, Storer B et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia. Blood 2002; 99: 2002–2008.

    Article  CAS  PubMed  Google Scholar 

  16. Champlin R, Passweg J, Zhang M et al. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood 2000; 95: 3996–4000.

    CAS  PubMed  Google Scholar 

  17. Ash R, Casper J, Chitambar C et al. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 1990; 322: 485–494.

    Article  CAS  PubMed  Google Scholar 

  18. Keever-Taylor C, Craig A, Molter M et al. Complement-mediated T-cell depletion of bone marrow: comparison on T10B9.1A-31 and Muromonab-Orthoclone OKT3. Cytotherapy 2001; 3: 467–481.

    Article  CAS  PubMed  Google Scholar 

  19. Prasad V, Kernan N, Heller G et al. DNA typing for HLA-A and HLA-B identified disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1. Blood 1999; 93: 399–409.

    CAS  PubMed  Google Scholar 

  20. Petersdorf E, Hansen J, Martin P et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med 2001; 345: 1794–1800.

    Article  CAS  PubMed  Google Scholar 

  21. Giebel S, Giogiani G, Marinetti M et al. Low incidence of severe acute graft-versus-host disease in children given hematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing. Bone Marrow Transplant 2003; 31: 987–993.

    Article  CAS  PubMed  Google Scholar 

  22. Davies S, Shu X, Blazar B et al. Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome. Blood 1995; 86: 1636–1642.

    CAS  PubMed  Google Scholar 

  23. Petersdorf E, Longton G, Anasetti C et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997; 89: 1818–1823.

    CAS  PubMed  Google Scholar 

  24. Johnston R, Geretti A, Grant P et al. HHB-6-related secondary graft failure following allogeneic bone marrow transplantation. Br J Haematol 1999; 105: 1041–1043.

    Article  CAS  PubMed  Google Scholar 

  25. Cohen A, Luger S, Sickles C et al. Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease. Bone Marrow Transplant 2002; 30: 23–28.

    Article  CAS  PubMed  Google Scholar 

  26. Broun E, Tricot G, Akard L et al. Treatment of refractory lymphoma with high dose cytarabine, cyclophosphamide and either TBI or VP-16 followed by autologous bone marrow transplantation. Bone Marrow Transplant 1990; 5: 341–344.

    CAS  PubMed  Google Scholar 

  27. Mehta J, Singhal S, Gee A et al. Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: a single-center experience of 201 patients. Bone Marrow Transplant 2004; 33: 389–396.

    Article  CAS  PubMed  Google Scholar 

  28. Godder K, Hazlett L, Abhyankar S et al. Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outcome. J Clin Oncol 2000; 18: 1856–1866.

    Article  CAS  PubMed  Google Scholar 

  29. Drobyski W, Klein J, Flomenberg N et al. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts. Blood 2002; 99: 806–814.

    Article  CAS  PubMed  Google Scholar 

  30. Handgretinger R, Klingebiel T, Lang P et al. Megadose transplantation of purified peripheral blood CD34+ progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 2001; 27: 777–783.

    Article  CAS  PubMed  Google Scholar 

  31. Locatelli F, Rocha V, Chastang C et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood 1999; 93: 3662–3671.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Oncology, The Children's Hospital of Philadelphia, USA

    N Bunin, R Aplenc, A Leahey, E Magira, S Grupp, G Pierson & D Monos

Authors
  1. N Bunin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Aplenc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Leahey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E Magira
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Grupp
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G Pierson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D Monos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N Bunin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bunin, N., Aplenc, R., Leahey, A. et al. Outcomes of transplantation with partial T-cell depletion of matched or mismatched unrelated or partially matched related donor bone marrow in children and adolescents with leukemias. Bone Marrow Transplant 35, 151–158 (2005). https://doi.org/10.1038/sj.bmt.1704754

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704754

Keywords

This article is cited by

Search

Advanced search

Quick links